awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36996728-7754B6C8-AC57-4F81-A41E-FB80BB6D5702
Q36996728-7754B6C8-AC57-4F81-A41E-FB80BB6D5702
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36996728-7754B6C8-AC57-4F81-A41E-FB80BB6D5702
New and emerging combination therapies for esophageal cancer.
P2860
Q36996728-7754B6C8-AC57-4F81-A41E-FB80BB6D5702
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36996728-7754B6C8-AC57-4F81-A41E-FB80BB6D5702
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2dfd9fe99e5308739a0353a6cbf7dab1cebc5029
P2860
Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction